A drug trial with 233 patients in Europe and North America revealed promising results for psilocybin as a treatment for depression. The test was undertaken by Compass Pathways a mental health care company.
From Stat:
— Read the restThe Phase 2b study is the largest randomized, controlled, double-blind trial of psilocybin, the psychedelic compound in magic mushrooms.